CD163 and neoplasm: Similarly to GBM03 and 04, GBM09 was characterized by the presence of CD3- and CD163-positive cells in both the PTA and TC, with a higher intensity and number of positive cells in neoplastic areas; TIGIT expression was found in the tumor core, while the periphery was almost completely negative for all the other analyzed markers.